Dexamethasone-induced insulin resistance and pancreatic adaptive response in aging rats are not modified by oral vanadyl sulfate treatment

European Journal of Endocrinology

Volumn 145, Issue 6, 2001, Pages 799-806

  Barbera, M ^a   Fierabracci, V ^a   Novelli, M ^a   Bombara, M ^a   Masiello, P ^a   Bergamini, E ^a   De Tata, V ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FATTY ACID; GLUCOCORTICOID; GLUCOSE; INSULIN; VANADYL SULFATE;

ADAPTATION; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; ISOLATED PANCREAS ISLET; LIPID METABOLISM; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PERFUSION; PRIORITY JOURNAL;

EID: 0035206987     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1450799     Document Type: Article

References (43)

1. The effect of aging on carbohydrate metabolism: A review of the English literature and a practical approach to diagnosis of diabetes mellitus
2. Glucose intolerance and aging
3. Glucose intolerance and aging. Evidence for tissue insensitivity to insulin
4. Mechanisms of insulin resistance in aging
5. Characterization of the insulin resistance of aging
6. Aging and insulin secretion
7. Insufficient adaptive capability of pancreatic endocrine function in dexamethasone-treated aging rats
8. Multifunctional actions of vanadium compounds on insulin signalling pathways: Evidence for preferential enhancement of metabolic versus mitogenic effects
9. In vivo insulin resistance in streptozotocin-diabetic rats - Evidence for reversal following oral vanadate treatment
10. Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate
11. Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats
12. Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats
13. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
14. β-Cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: Impairment in adipocyte-β-cell relationships
15. Fatty acids, lipotoxicity and insulin secretion
16. Pancreatic β-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids
17. A rat pancreas-small gut preparation for the study of intestinal factor(s) and insulin release
18. Coated charcoal immunoassay of insulin
19. Effect of vanadate on elevated blood glucose and depressed cardiac performance in diabetic rats
20. Oral vanadyl sulphate in treatment of diabetes mellitus in rats
21. The protein phosphatase inhibitor, pervanadate, is a powerful antidiabetic agent in streptozotocin-treated rats
22. Long-term effects of vanadate treatment on glycogen metabolizing and lipogenic enzymes of liver in genetically diabetic (db/db) mice
23. Nutritional factors that can favourably influence the glucose/insulin system: Vanadium
24. Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinaemic fa/fa rats
25. Vanadate normalizes hyperglycaemia and phosphoenolpyruvate carboxy-kinase mRNA levels in ob/ob mice
26. Oral vanadate decreases muscle insulin resistance in obese fa/fa rats
27. The insulin-like properties of vanadium: A curiosity or a perspective for the treatment of diabetes?
28. Leptin: Its role in obesity and beyond
29. Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women
30. Induction of ob gene expression by corticosteroids is accompagned by body weight loss and reduced food intake
31. Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozotocin-diabetic and dexamethasone-treated rats: Role of hyperglycaemia and increased β-cell demand
32. Effect of age, diet and obesity on insulin secretion from isolated perfused rat pancreas: Response to glucose, arginine and glucagon-like peptide 1 (7-37)
33. Insulin secretion in vitro by pancreatic tissue from normal, adrenal-ectomized, and cortisol-treated rats
34. On the role of glucocorticoid in glucose-induced insulin secretion
35. Roles of insulin resistance and beta-cell disfunction in dexa-methasone-induced diabetes
36. Evidence of a paracrine role of neuropeptide-Y in the regulation of insulin release from pancreatic islets of normal and dexamethasone-treated rats
37. Effect of hydrocortisone on terbutaline stimulated insulin release from isolated pancreatic islets
38. Islet amyloid polypeptide and insulin secretion from isolated perfused pancreas of fed, fasted, glucose-treated, and dexamethasone-treated rats
39. Glucocorticoid increases glucose cycling and inhibits insulin release in pancreatic islets of ob/ob mice
40. Direct glucocorticoid inhibition of insulin secretion An in vitro study of dexamethasone effects in mouse islets
41. Vanadyl differently influences insulin response to glucose in isolated pancreas of normal rats after in vivo exposure
42. Mechanism of insulin-like action of vanadyl sulfate: Studies on interaction between rat adipocytes and vanadium compounds
43. Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in β-cells